Recent global events like pandemics, geopolitical conflicts and extreme weather have exposed the fragility of complex, globally dispersed supply chains in the pharma and medtech sectors. Understanding these complexities, Mahesh Wade, SCM Cluster Head South Asia, B Braun Group expressed how building supply chains that are not only efficient but also resilient is no longer optional—it’s essential.
Wade highlights that this shift requires rethinking traditional models. Distributed distribution networks can reduce dependency on single regions and improve responsiveness. Investing in last-mile delivery solutions is crucial to ensure timely and secure access to temperature-sensitive drugs and personalised therapies. Enhanced traceability, powered by digital tools, strengthens quality control and regulatory compliance. Addressing diverse geographic and demographic needs further supports equitable access to critical therapies.
Key strategies to fortify supply chains include comprehensive risk assessments, robust contingency planning, and sustained investment in digital transformation. Strong collaboration with partners, effective communication, and well-integrated quality management systems are equally critical. Scenario planning and simulation exercises help stress-test operations, while circular economy principles bring added resilience through waste reduction and resource efficiency.